enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.740
-0.010 (-0.57%)
At close: Jun 17, 2026, 4:00 PM EDT
1.755
+0.015 (0.86%)
After-hours: Jun 17, 2026, 6:57 PM EDT
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $116.56 million as of June 17, 2026. Its market cap has decreased by -45.66% in one year.
Market Cap
116.56M
Enterprise Value
-108.55M
1-Year Change
-45.66%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has decreased from $155.91M to $116.56M, a decrease of -25.24%. That is a compound annual growth rate of -6.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 116.56M | -80.73% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agenus | 123.26M |
| Spero Therapeutics | 122.17M |
| NeOnc Technologies Holdings | 121.77M |
| Pyxis Oncology | 120.38M |
| Jyong Biotech | 118.77M |
| Coya Therapeutics | 117.99M |
| PepGen | 117.59M |
| Alps Group | 116.15M |